Skip to main content

Advertisement

Table 1 Age and body mass indices (BMI) of men in each caffeine treatment group (means ± SEM)

From: Caffeine administration does not alter salivary α-amylase activity in young male daily caffeine consumers

  Caffeine treatment Ggroups
  Placebo (N = 15) 200 mg (N = 15) 400 mg (N = 15)
Age (years) 22.00 ± 0.60 20.67 ± 0.58 21.07 ± 0.80
Body mass index (kg/m2) 23.43 ± 0.70 23.64 ± 0.80 23.11 ± 0.57